Advertisement

Neurogene Mechanismen der Hautdurchblutung

  • F. Lembeck
Conference paper
Part of the Der Hautarzt book series (VDGDERMATOLOGIE, volume 34)

Zusammenfassung

Die Durchblutung der Haut wird durch verschiedenartige Mechanismen geregelt. Diese Regelung erlaubt, daß der Blutstrom in manchen Arealen bis auf das tausendfache der minimalen Durchblutung ansteigen kann [7]. Das Ausmaß der Regulation ist in verschiedenen Hautarealen unterschiedlich. Eine Änderung der Hautdurchblutung kann, im Rahmen der Temperatur- oder der Kreislaufregulation fast alle Hautareale betreffen, sie kann aber auch auf ein kleines Areal beschränkt sein, wie beispielsweise bei lokalen entzündlichen Vorgängen, beim Axonreflex oder bei Kälteexposition (Tabelle 1).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Bernstein JE, RM Swift, Keyoumars Soltani, AL Lorincz (1981) Inhibition of axon reflex vasodilatation by topically applied capsaicin. J Invest Dermatol 76:394–395PubMedCrossRefGoogle Scholar
  2. 2.
    Bito LZ, RR Nichols, RA Baroody (1982) A comparison of the miotic and inflammatory effects of biologically active polypeptides and prostaglandin E2 on the rabbit eye. Exp Eye Res 34:325–337PubMedCrossRefGoogle Scholar
  3. 3.
    Bloom SR, Polak JM (1983) Regulatory peptides and the skin. Clin Exp Dermatol 8:3–18PubMedCrossRefGoogle Scholar
  4. 4.
    Borkowski KR, M Porter (1985) Reduced ß-adrenoreceptormediated vasodilatation in spontaneously hypertensive rats. Br J Pharmac 84:158PGoogle Scholar
  5. 5.
    Camp RDR, AA Coutts, MW Graeves, AB Kay, MJ Walport (1983) Responses of human skin to intradermal injection of leukotrienes C4, D4 and B4. Br J Pharmac 80:497–502Google Scholar
  6. 6.
    Chahl LA, J Szolcsányi, F Lembeck (Eds.) Antidromic vasodilatation and neurogenic inflammation. Akadémiai Kiadó, Budapest 1984Google Scholar
  7. 7.
    Clark N, OG Edholm (1984) Man and his thermal environment. Edward Arnold, LondonGoogle Scholar
  8. 8.
    Donnerer J, F Lembeck (1983) Heat loss reaction to capsaicin through a peripheral site of action. Br J Pharmac 79:719–723Google Scholar
  9. 9.
    Dobbins DE, CY Soika, AJ Premen, GJ Grega, JM Dobney (1982) Blockade of histamine and bradykinin-induced increases in lymph flow, protein concentration, and protein transport by terbutaline in vivo. Microcirculation 2:127–150Google Scholar
  10. 10.
    Dupont AG, RA Lefebvre, MG Bogaert (1985) Inhibitory effects of apomorphine and pergolide on neurogenic vasoconstrictor in the hindquarters of the rat. Naunyn-Schmiedeberg’s Arch Pharmacol, in pressGoogle Scholar
  11. 11.
    Edholm OG, RH Fox, RK Macpherson (1957) Vasomotor control of the cutaneous blood vessels in the human fore arm. J Physiol 139:455–465PubMedGoogle Scholar
  12. 12.
    Foreman JC, CC Jordan, P Oehme, H Renner (1983) Structure-activity relationships for some substance P-related peptides that cause wheal and flare reactions in human skin. J Physiol 335:449–465PubMedGoogle Scholar
  13. 13.
    Fügner A (1977) Inhibition of antigen-induced histamine release by ß-adrenergic stimulants in vivo. Int Arch Allergy Appl Immunol 54:78–87PubMedCrossRefGoogle Scholar
  14. 14.
    Gamse R, P Holzer, F Lembeck (1980) Decrease of substance P in primary afferent neurones and impairment of neurogenic plasma extravasation by capsaicin. Br J Pharmac 68:207–213Google Scholar
  15. 15.
    Gamse R (1984) Physiologie und Pathophysiologie der Substanz P. Arzneimittel Forsch 34:1–6Google Scholar
  16. 16.
    Gamse R, A Saria (1985) Potentiation of tachykinin-induced plasma protein extravasation by calcitonin generelated peptide. Zur Publikation eingereichtGoogle Scholar
  17. 17.
    Gamillscheg A, P Holzer, J Donnerer, F Lembeck (1984) Effect of neonatal treatment with capsaicin on carrageenaninduced paw oedema in the rat. Naunyn-Schmiedeberg’s Arch Pharmacol 326:340–342CrossRefGoogle Scholar
  18. 18.
    Ibrahim FD, G Stella, M Talaat (1951) The mechanism of antidromic vasodilatation. Quart J Exp Physiol 36:189–198PubMedGoogle Scholar
  19. 19.
    Jänig W (1984) Prinzipien der Organisation des sympathischen Nervensystems. In Fischer PA (Ed.), Vegetative Störungen beim Parkinson Syndrom. Editiones Roche, Basel: p. 9–32Google Scholar
  20. 20.
    Kaada B, KB Helle (1984) In search of mediators of skin vasodilatation induced by transcutaneous nerve stimulation. Gen Pharmac 15:115–122CrossRefGoogle Scholar
  21. 21.
    Kenins P, JV Hurley, C Bell (1984) The role of substance P in the axon reflex in the rat. Br J Dermatol 111:551–559PubMedCrossRefGoogle Scholar
  22. 22.
    Koo A (1984) Vasodilator effect of terbutaline: in vivo evidence for the existence of ß2-adrenoceptors in the microcirculation of rats, hamsters, and guinea-pigs. J Cardiovasc Pharmacol 6:897–901PubMedCrossRefGoogle Scholar
  23. 23.
    Laduron PM (1985) Presynaptic heteroreceptors in regulation of neuronal transmission. Biochem Pharmacol 34:467–470PubMedCrossRefGoogle Scholar
  24. 24.
    Lembeck F, H Popper, H Juan (1976) Release of prostaglandins by bradykinin as an intrinsic mechanism of its algesic effect. Naunyn-Schmiedeberg’s Arch Pharmacol 294:69–73CrossRefGoogle Scholar
  25. 25.
    Lembeck F, P Holzer (1979) Substance P as neurogenic mediator of antidromic vasodilatation and plasma extravasation. Naunyn-Schmiedeberg’s Arch Pharmacol 310:175–183CrossRefGoogle Scholar
  26. 26.
    Lembeck F, J Donnerer (1981) Postocclusive cutaneous vasodilatation mediated by substance P. Naunyn-Schmiedeberg’s Arch Pharmacol 316:165–171CrossRefGoogle Scholar
  27. 27.
    Lembeck F (1983) Sir Thomas Lewis’s nocifensor system, histamine and substance P-containing primary afferent nerves. Trends in Neuroscience 6:106–108CrossRefGoogle Scholar
  28. 28.
    Lembeck F (1983) Mediators of vasodilatation in the skin. Br J Dermatol 109, Suppl 25:1–9PubMedGoogle Scholar
  29. 29.
    Lembeck F. (1985) Substance P and sensory neurons. In: Symposium on Substance P. Maidstone 1984, im DruckGoogle Scholar
  30. 30.
    Lembeck F, R Amann (1985) Inhibition of neurogenic plasma extravasation. Unveräffentlichte ErgebnisseGoogle Scholar
  31. 31.
    Lundberg JM, A Saria (1983) Capsaicin-induced desensitization of airway mucosa to cigarette smoke, mechanical and chemical irritants. Nature (Lond.) 302:251–253CrossRefGoogle Scholar
  32. 32.
    Miller MS, SH Buck, I Glenn Sipes, HI Yamamura, TF Burks (1982) Regulation of substance P by nerve growth factor: disruption by capsaicin. Brain Research 250:193–196PubMedCrossRefGoogle Scholar
  33. 33.
    Morley J, CP Page, W Paul (1983) Inflammatory actions of platelet activating factor (Paf-acether) in guinea-pig skin. Br J Pharmac 80:503–509Google Scholar
  34. 34.
    O’Donnell SR, CGA Persson (1978) ß-Adrenoreceptor mediated inhibition by terbutaline of histamine effects on vascular permeability. Br J Pharmac 62:321–324Google Scholar
  35. 35.
    Persson CGA, I Erjefalt (1979) Terbutaline and adrenaline inhibit leakage of fluid and protein in guinea-pig lung. Eur J Pharmacol 55:199–201PubMedCrossRefGoogle Scholar
  36. 36.
    Rowell LB (1981) Active neurogenic vasodilatation in man. In Vanhoutte PM and Lensen I (Eds.), Vasodilatation, Raven Press: p. 1–17Google Scholar
  37. 37.
    Russel LC, KJ Burchiel (1984) Neurophysiological effects of capsaicin. Brain Research Reviews 8:165–176CrossRefGoogle Scholar
  38. 38.
    Saria A, JM Lundberg, G Skofitsch, F Lembeck (1983) Vascular protein leakage in various tissues induced by substance P, capsaicin, bradykinin, serotonin, histamine and by antigen challenge. Naunyn-Schmiedeberg’s Arch Pharmacol 324:212–218CrossRefGoogle Scholar
  39. 39.
    Saria A (1984) Substance P in sensory nerve fibres contributes to the development of oedema in the rat hind paw after thermal injury. Br J Pharmac 82:217–222Google Scholar
  40. 40.
    Saria A, E Theodorsson, R Gamse, JM Lundberg (1985) Release of substance P- and substance K-like immunoreactivities from the isolated perfused guinea-pig lung. Eur J Pharmacol 106:207–208CrossRefGoogle Scholar
  41. 41.
    Stevens MJ, RE Rittinghausen, RL Medcolf, RFW Moulds (1982) Prejunctional ß-adrenoreceptors in human digital arteries. Eur J Pharmacol 83:263–270PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • F. Lembeck
    • 1
  1. 1.Institut für exp. und klin. PharmakologieGrazAustria

Personalised recommendations